Sabino Strippoli

Circulating extracellular vesicles expressing PD1 and PD-L1 predict response and mediate resistance to checkpoint inhibitors immunotherapy in metastatic melanoma

Simona Serratì, Michele Guida, R. Fonte et al. · Molecular Cancer · 2022 · 148 citations · Full text

Life Sciences, Immunology, Oncology +17

Basal and one-month differed neutrophil, lymphocyte and platelet values and their ratios strongly predict the efficacy of checkpoint inhibitors immunotherapy in patients with advanced BRAF wild-type melanoma

Michele Guida, Nicola Bartolomeo, Davide Quaresmini et al. · Journal of Translational Medicine · 2022 · 67 citations · Full text

Medicine, Hematology, Oncology +16

Immune checkpoint inhibitor associated vitiligo and its impact on survival in patients with metastatic melanoma: an Italian Melanoma Intergroup study

Michele Guida, Sabino Strippoli, Milena Maule et al. · ESMO Open · 2021 · 57 citations · Full text

Medicine, Dermatology, Oncology +17

Cemiplimab in an Elderly Frail Population of Patients With Locally Advanced or Metastatic Cutaneous Squamous Cell Carcinoma: A Single-Center Real-Life Experience From Italy

Sabino Strippoli, Annarita Fanizzi, Davide Quaresmini et al. · Frontiers in Oncology · 2021 · 46 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Aurora kinase B inhibition reduces the proliferation of metastatic melanoma cells and enhances the response to chemotherapy

Letizia Porcelli, Gabriella Guida, Anna Elisa Quatrale et al. · Journal of Translational Medicine · 2015 · 45 citations · Full text

Medicine, Oncology, Pharmacology +17